Ethylene Glycol Residual Content Testing Procedure: A Complete Technical Guide

Ethylene glycol residual content testing is a critical quality control procedure used to quantify trace amounts of ethylene glycol remaining in medical devices, polymers, packaging materials, and sterilized products. This technical guide outlines a standardized inspection procedure covering sample preparation, gas chromatographic analysis, calibration, calculation, and acceptance criteria to ensure product safety and regulatory compliance. Laboratories and manufacturers can follow this procedure to establish validated, reproducible testing protocols for ethylene glycol residue determination.

Technical Overview

This procedure establishes a systematic method for the quantitative determination of ethylene glycol (EG, CAS 107-21-1) residual content in materials and finished products. Ethylene glycol residues may originate from polycondensation processes in polyester production, ethylene oxide sterilization byproducts, or the use of glycol-based processing aids. Because ethylene glycol exhibits dose-dependent toxicity, including metabolic conversion to oxalic acid and potential renal and central nervous system effects, residual levels must be strictly controlled and verified through validated analytical testing.

The core analytical principle of this procedure is gas chromatography with flame ionization detection (GC-FID). Sample extracts containing residual ethylene glycol are injected into the chromatographic system, where components are separated on a polar capillary column and quantified against an external calibration standard. The method is applicable to aqueous extracts, solvent extracts, and headspace sampling configurations depending on the sample matrix.

• Purpose: To define unified requirements for reagents, instruments, sampling, extraction, chromatographic analysis, and result calculation for ethylene glycol residual content determination.
• Scope: Applicable to single-use medical devices, sterilized products, polyester resins and products, packaging materials, textiles, and chemical intermediates.
• Reference standards: ISO 10993 series (biological evaluation of medical devices), national pharmacopoeia monographs on residual solvents, GB/T 14233.1 test methods for medical devices, and applicable product-specific technical standards.
• Safety requirements: Ethylene glycol is harmful if ingested, inhaled, or absorbed through skin. Analysts must wear protective gloves, lab coats, and eye protection, and all operations involving standards and extracts shall be performed in a fume hood or well-ventilated area.

Testing Samples

Medical Devices and Sterilization Byproducts

Single-use medical devices sterilized with ethylene oxide may contain ethylene glycol as a reaction byproduct formed from ethylene oxide hydrolysis. Devices made from polymeric materials such as catheters, tubing sets, dialyzers, wound dressings, and surgical drapes shall be tested in their final, sterilized, and packaged condition to reflect actual residual levels delivered to the patient.

Polyester and Polymer Materials

Polyethylene terephthalate (PET) resins, films, bottles, and polyester fibers retain trace amounts of unreacted ethylene glycol from the polymerization stage. Samples should be taken from finished pellets, molded parts, or spun fibers, and representative sampling plans should account for lot uniformity and process variation.

Packaging and Food Contact Materials

Food packaging, beverage containers, and cosmetic packaging manufactured from glycol-modified polymers require residual verification to prevent migration of ethylene glycol into contained products. Both the material itself and migration simulants may be tested according to applicable food contact regulations.

Chemical and Pharmaceutical Products

Pharmaceutical excipients, antifreeze formulations, hydraulic fluids, humectants, and intermediates may require confirmation of free ethylene glycol content within specification limits defined by the product quality standard.

Testing Items

The primary testing item is the residual ethylene glycol content of the sample, expressed in milligrams per liter (mg/L) of extract, micrograms per gram (μg/g) or milligrams per kilogram (mg/kg) of sample, or as total residue per device (mg/device) for medical products. Depending on the product specification, the following determinations may be included in the test plan:

• Quantitative determination of free ethylene glycol residual content in the sample extract.
• Combined glycol residual determination, including ethylene glycol and diethylene glycol (DEG), where both residuals are specified.
• Complementary residual analysis for ethylene oxide (EO) and ethylene chlorohydrin (ECH) when the sample has undergone ethylene oxide sterilization.
• Migration or extraction studies to estimate the deliverable dose of ethylene glycol under simulated clinical or end-use conditions.

Testing Methods

Reagents, Materials, and Equipment

• Reference standard: ethylene glycol reference substance with certified purity, or a commercially certified standard solution.
• Extraction solvent: purified water (distilled or deionized), or a validated solvent such as methanol or acetonitrile where appropriate for the matrix.
• Instrument: gas chromatograph equipped with a flame ionization detector (FID), split/splitless injector, and an autosampler.
• Chromatographic column: polar capillary column with a polyethylene glycol (PEG/WAX-type) stationary phase, typically 30 m in length, 0.32 mm inner diameter, 0.25 μm film thickness, or an equivalent column of demonstrated suitability.
• Auxiliary equipment: analytical balance (readability 0.1 mg), constant-temperature water bath or incubator, volumetric flasks, pipettes, membrane filters (0.45 μm or finer), and headspace vials where headspace sampling is applied.

Sample Preparation and Extraction

Sample preparation shall be performed under conditions that prevent contamination, loss of analyte, and cross-contamination between samples. The extraction conditions should simulate the intended use of the product or provide exhaustive extraction, as defined by the applicable standard.

• Sample conditioning: condition the test sample at the temperature specified by the product standard (commonly 20–25 °C) prior to extraction, and record the conditioning temperature and humidity.
• Aqueous extraction for medical devices: weigh or measure a defined quantity of the sample, add a measured volume of purified water at a documented surface-area-to-volume or mass-to-volume ratio, and extract in a sealed container at 37 °C for a defined period (commonly 1 to 24 hours) to simulate patient contact conditions.
• Solvent extraction for polymers: accurately weigh a homogeneous portion of the sample (typically 0.5–2 g), extract with a measured volume of suitable solvent under reflux or sonication, cool, and dilute to volume.
• Blank preparation: prepare a reagent blank following the same procedure without the sample to verify the absence of interference.
• Filtration: filter the extract through a 0.45 μm membrane filter before injection, discarding the first portion of filtrate.

Chromatographic Conditions

Typical GC-FID parameters are listed below. Exact conditions shall be optimized and verified during method validation to achieve adequate resolution, peak symmetry, and system suitability.

• Column: polyethylene glycol polar capillary column, 30 m × 0.32 mm × 0.25 μm (or equivalent).
• Column temperature program: initial hold at approximately 60 °C, ramped at 10 °C/min to 220 °C, with a final hold until all components are eluted; a constant temperature near 180–200 °C may also be suitable for simple matrices.
• Injector temperature: 220–250 °C; injection mode: split injection with an appropriate split ratio (e.g., 10:1 to 50:1) or splitless injection for trace-level analysis.
• Detector (FID) temperature: 250–280 °C.
• Carrier gas: nitrogen or helium at a constant flow of approximately 1–2 mL/min; combustion gases for FID: hydrogen and dry air per instrument specification.
• Injection volume: 1 μL for liquid injection; headspace sampling may be applied with an equilibration temperature of 120–150 °C and an equilibration time of 30–45 minutes, provided the method is validated for ethylene glycol recovery.

Calibration and Quantification

• Stock standard solution: accurately weigh an appropriate quantity of ethylene glycol reference standard and dilute to volume with the extraction solvent to prepare a stock solution of known concentration.
• Working standards: prepare at least five concentration levels spanning the expected sample concentration range, and store under validated conditions.
• Calibration curve: inject each working standard, plot the peak area against concentration, and obtain the linear regression equation with its correlation coefficient; the correlation coefficient should typically be not less than 0.995.
• External standard method: quantify ethylene glycol in sample extracts by comparing the sample peak area with the calibration curve, after confirming that the retention time matches the standard within the permitted tolerance.
• System suitability: verify repeatability of replicate standard injections (RSD typically not more than 2–5%), resolution from adjacent peaks (not less than 1.5), and absence of interfering peaks in the blank.

Calculation of Results

The ethylene glycol residual content is calculated using the external standard method according to the following relationships:

• Concentration in extract: determine the ethylene glycol concentration C (mg/L) in the test extract from the calibration curve, corrected for dilution factors.
• Residual content by mass: Residual EG (mg/kg) = (C × V × F) / m, where C is the concentration in the extract (mg/L), V is the total extract volume (L), F is any dilution factor, and m is the sample mass (kg).
• Residue per device: Residual EG (mg/device) = (C × V × F) / N, where N is the number of devices extracted.
• Result reporting: report results to the appropriate number of significant figures, state the extraction conditions, and compare against the specification limit. If the result exceeds the limit, confirm with a duplicate determination and investigate potential causes.

Method Validation and Quality Control

• Specificity: demonstrate that ethylene glycol is free from interference from the sample matrix, extraction solvent, and co-eluting residuals.
• Linearity: verify linearity across the working range with a correlation coefficient meeting the predefined criterion.
• Accuracy and precision: evaluate recovery through spiked samples (acceptable recovery typically 85–115%, or per the validated criteria) and assess repeatability and intermediate precision.
• Detection capability: establish the limit of detection (LOD) and limit of quantification (LOQ) as appropriate for the specification level.
• Quality control: include a reagent blank, a continuing calibration verification standard, and a spiked sample or QC sample with each analytical batch.

Applications

This testing procedure is widely applied across industries where ethylene glycol residues present a safety, quality, or regulatory concern:

• Medical device manufacturing: verification of residual ethylene glycol and related sterilization byproducts on ethylene oxide sterilized devices to support biocompatibility evaluation under the ISO 10993 framework and product release.
• Polymer and polyester production: quality control of PET resins, films, fibers, and glycol-modified polymers to confirm completion of polymerization and compliance with material specifications.
• Food and cosmetic packaging: assessment of residual monomer levels and migration behavior for food contact compliance and consumer safety.
• Pharmaceutical and chemical industries: confirmation of free glycol content in excipients, intermediates, and formulated products against pharmacopoeial or contractual limits.
• Regulatory submission and auditing: generation of defensible analytical data for product registration, batch release, and third-party laboratory verification.

FAQ

Why is ethylene glycol residue testing required?

Ethylene glycol is toxic upon significant exposure, and residues can migrate from materials during product use. Regulatory standards and product specifications therefore impose limits on residual ethylene glycol, and validated testing is required to demonstrate compliance before product release.

What is the typical specification limit for ethylene glycol residue?

Limits depend on the product type, contact route, and applicable standard. Medical device residues are typically evaluated against tolerable exposure criteria defined in ISO 10993-7 and product-specific standards, while polymer and packaging materials follow limits defined in material specifications or food contact regulations. The applicable limit should always be confirmed against the governing standard for the specific product.

Which analytical technique is most suitable for ethylene glycol residue determination?

GC-FID with direct liquid injection of an aqueous or solvent extract is the most common approach because it offers adequate sensitivity and simplicity. Headspace GC and derivatization-based GC methods can improve sensitivity for demanding matrices, and HPLC methods may be used as validated alternatives when volatility limitations affect GC performance.

How are samples handled to ensure accurate results?

Samples should be sealed in clean, inert containers immediately after collection, protected from contamination and temperature extremes, and analyzed within the validated holding time. Volatile loss, incomplete extraction, and environmental contamination are the primary sources of result error and must be controlled.

How long does a typical ethylene glycol residue test take?

Following extraction, chromatographic analysis of each sample typically requires 15 to 40 minutes per injection. Including sample conditioning, extraction, calibration, and duplicate confirmation, a complete test is generally completed within one to three working days, depending on the extraction protocol specified by the product standard.